CX Partners-backed Veeda Lifesciences eyes majority stake sale at upto $400 million valuation

Mumbai, Oct. 7 -- Veeda Lifesciences has relaunched the process of exploring a majority stake sale in a deal that will value the company at $300-400 million and facilitate exits for its existing shareholders, three people familiar with the matter said."The deal will entail a majority stake sale - t…